参考文献/References:
[1] 国家心血管病中心心肌病专科联盟,中国医疗保健国际交流促进会心血管病精准医学分会“中国成人肥厚型心肌病诊断与治疗指南2023”专家组. 中国成人肥厚型心肌病诊断与治疗指南2023[J]. 中国循环杂志,2023,38(1):1-33.
[2] Ommen SR,Ho CY,Asif IM,et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the management of hypertrophic cardiomyopathy:a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines[J]. Circulation,2024,149(23):e1239-e1311.
[3] Maron MS,Olivotto I,Zenovich AG,et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction[J]. Circulation,2006,114 (21):2232-2239.
[4] Nguyen A,Schaff HV,Hang D,et al. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy:a propensity score-matched cohort [J]. J Thorac Cardiovasc Surg,2019,157(1):306-315.
[5] 刘丽文,左蕾,周梦垚,等. 经胸超声心动图引导下经皮心肌内室间隔射频消融术治疗梗阻性肥厚型心肌病的安全性和有效性[J]. 中华心血管病杂志,2019,4(74):284-290.
[6] Liu L,Li J,Zuo L,et al. Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy[J]. J Am Coll Cardiol,2018,7(216):1898-1909.
[7] Talreja DR,Nishimura RA,Edwards WD,et al. Alcohol septal ablation versus surgical septal myectomy:comparison of effects on atrioventricular conduction tissue[J]. J Am Coll Cardiol,2004,44(12):2329-2332.
[8] Chan W,Williams L,Kotowycz MA,et al. Angiographic and echocardiographic correlates of suitable septal perforators for alcohol septal ablation in hypertrophic obstructive cardiomyopathy[J]. Can J Cardiol,2014,30(8):912-919.
[9] Agarwal S,Tuzcu EM,Desai MY,et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy[J]. J Am Coll Cardiol,2010,55(8):823-834.
[10] He G,Sun C,Zhang X,et al. Echocardiography-guided percutaneous per-ventricular laser
ablation of ventricular septum:in vivo study in a canine model[J]. Lasers Med Sci,2016,31(4):645-651.
[11] 张相空,刘丽文,孙超,等. 超声引导激光消融犬室间隔的实验研究[J]. 中华超声影像学杂志,2015,24(11):996-999.
[12] Fu J,Sun C,Liu F,et al. Transthoracic echocardiography guided percutaneous laser ablation of the interventricular septum:a successful sheep model for septal thickness reduction and one year follow-up[J]. Int J Cardiol ,2019,280(1):135-141.
[13]Shi Y,Zhai B. A recent advance in image-guided locoregional therapy for hepatocellular carcinoma[J]. Gastrointest Tumors,2016,3(2):90-102.
[14] Liu F,Fu J,Hsi D,et al. Percutaneous intramyocardial septal radiofrequency ablation for interventricular septal reduction:an ovine model with 1-year outcomes[J]. Cardiology,2020,145(1):53-62.
[15] Liu L,Liu B,Li J,et al. Percutaneous intramyocardial septal radiofrequency ablation of hypertrophic obstructive cardiomyopathy:a novel minimally invasive treatment for reduction of outflow tract obstruction[J]. EuroIntervention,2018;13(18):e2112-e2113.
[16] Zhou M,Ta S,Hahn RT,et al. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractoryhypertrophic obstructive cardiomyopathy[J]. JAMA,Cardiol,2022,7(5):529-538.
[17] Xie X,Chen S,Cui Y,et al. Midterm outcomes of percutaneous intramyocardial septal radiofrequency ablation for hypertrophic cardiomyopathy:a single-center,observational study[J]. J Am Heart Assoc,2024,13(15):e034080.
[18] Wu B,Zhou Y,Lu J,et al. Interventricular septal hematoma caused by percutaneous intramyocardial septal radiofrequency ablation successfully treated with coil embolization[J]. JACC Cardiovasc Interv,2023,16(6):722-724.
[19] Ta S,Li J,Hsi DH,et al. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up[J]. Heart,2024,110(11):792-799.
[20] Cui H,Schaff HV,Abel MD,et al. Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis[J]. J Thorac Cardiovasc Surg,2020,59(3):844-852.
[21] Desai MY,Alashi A,Popovic ZB,et al. Outcomes in patients with obstructive hypertrophic cardiomyopathy and concomitant aortic stenosis undergoing surgical myectomy and aortic valve replacement[J]. J Am Heart Assoc,2021,10(18):e018435.
[22] Li Y,Feng Y,Li X,et al. Case report:minimally invasive therapy by transcatheter aortic valve replacement and percutaneous intramyocardial septal radiofrequency ablation for a patient with aortic stenosis combined with hypertrophic obstructive cardiomyopathy:two-year follow-up results[J]. Front Cardiovasc Med,2021,8:735219.
[23] Liu L,Zhou M,Zuo L,et al. Echocardiography guided Liwen procedure??for the treatment of obstructive hypertrophic cardiomyopathy in a patient with prior aortic valve replacement surgery:Liwen procedure for intra-myocardial radiofrequency ablation[J]. Echocardiography,2018,35(8):1230-1232.
[24] Cho YH,Quintana E,Schaff HV,et al. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy mechanisms of obstruction and outcomes of reoperation[J]. JThorac Cardiovasc Surg,2014,148(3):909-915.
[25] Wang H,Lei C,Liu L. A case report of percutaneous intramyocardial septal radiofrequency ablation in an adult with re-obstruction after Morrow procedure[J]. Eur Heart J Case Rep,2024,8(4):ytae145.
[26] Xu Y,Yu TY,Pu ZX. Percutaneous intramyocardial septal radiofrequency ablation relieving residual left ventricular outflow tract obstruction following alcohol septal ablation[J]. CASE (Phila) ,2022,6(7):340-343.
[27] 刘丽文. Liwen术式治疗肥厚型心肌病:从基础到临床应用实践[M]. 北京:科学出版社,2021.
[28] Zuo L,Hsi DH,Zhang L,et al. Electrocardiographic QRS voltage amplitude improvement by intramyocardial radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy and one year follow up[J]. J?Electrocardiol,2020,61:164-169.
[29] Savage DD,Seides SF,Clark CE,et al. Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy[J]. Circulation,1978,58(3Pt1):402-408.
[30] 徐博,刘金成,李静,等. Liwen术式治疗肥厚型心肌病合并完全性右束支传导阻滞的临床研究[J]. 中华医学超声杂志(电子版),2020,17(5):421-426.
[31] 拓胜军,刘丽文,周梦垚,等. 超声引导下经皮心肌内室间隔射频消融术治疗梗阻性肥厚型心肌病不增加心律失常风险:小样本一年随访研究[J]. 中华医学超声杂志(电子版),2020,17(5):416-420.
[32] 李莹,拓胜军,王静,等. 超声引导下经皮心肌内室间隔射频消融术治疗梗阻性肥厚型心肌病对Lown分级的影响[J]. 中华超声影像学杂志,2023,32(4):288-294.
[33] 刘莎,马志玲,邵虹,等. 经皮心肌内室间隔射频消融术治疗梗阻性肥厚型心肌病术后心电的变化[J]. 中国心脏起搏与心电生理杂志,2024,38(2):100-104.
[34] Lee HJ,Kim HK,Lee SC,et al. Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy[J]. Eur Heart J Cardiovasc Imaging,2022,23(8):1108-1116.
[35] Qian D ,Zhou X,Liu H,et al. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy[J]. J Clin Ultrasound,2021,49(6):554-562.
[36] Li J ,Zhang J,Shi Y,et al. Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation[J]. Heart,2023,109(4):289-296.
[37] Konst RE,Guzik TJ,Kaski JC,et al. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions[J]. Cardiovasc Res,2020,116(4):817-828.
[38] Yao L,Ta S,Wang J,et al. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy:a study of myocardial contrast echocardiography[J]. Int J Cardiovasc Imaging,2024,40(7):1483-1492.
[39] 韩超,周梦垚,吴剑锋,等. Liwen术式心肌活检：通过新的活检方式获得的HCM患者心肌标本的代表性及其病因学诊断价值[J]. 中华心血管病杂志,2022,50(4):361-368.
相似文献/References:
[1]冯坤,刘春霞,熊峰,等.超声心动图在肥厚型心肌病诊治中的应用进展[J].心血管病学进展,2016,(4):409.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.021]
FENG Kun,LIU Chunxia,XIONG Feng,et al.Progress in Application of Echocardiography in
Diagnosis and Treatment of Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2016,(11):409.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.021]
[2]黄淮滨 刘甲兴.肥厚型心肌病治疗新靶点——钙脱敏治疗[J].心血管病学进展,2019,(7):1047.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.021]
HUANG HuaibinLIU Jiaxing.A Novel Target for Therapy in Hypertrophic Cardiomyopathy: Ca2+ desensitizer[J].Advances in Cardiovascular Diseases,2019,(11):1047.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.021]
[3]马秀英 贾锋鹏.肥厚型心肌病并发心房颤动的危险因素研究进展[J].心血管病学进展,2020,(12):1243.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.005]
MA XiuyingJIA Fengpeng.Update about the Risk Factors of Hypertrophic Cardiomyopathy Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(11):1243.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.005]
[4]邓清文,何森.肥厚型心肌病合并心房颤动的研究进展[J].心血管病学进展,2021,(4):27.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.010]
DENG Qingwen,HE Sen.Hypertrophic Cardiomyopathy Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(11):27.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.010]
[5]尚依一 刘罗 庞明杰 张艳.基因检测在肥厚型心肌病中的应用进展[J].心血管病学进展,2021,(6):512.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.009]
SHANG Yiyi,LIU Luo,PANG Mingjie,et al.Gene Detection for Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(11):512.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.009]
[6]王娟 杨艳敏.肥厚型心肌病发生缺血性卒中的危险因素和管理策略研究进展[J].心血管病学进展,2021,(7):582.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.002]
WANG Juan,YANG Yanmin.Risk Factors and Management Strategies of Ischemic Stroke in Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(11):582.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.002]
[7]武志刚 孙佳莉 王巍.基于心脏磁共振成像的肥厚型心肌病患者早期峰值充盈率与舒张功能相关性的研究[J].心血管病学进展,2021,(7):658.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.020]
WU Zhigang,SUN Jiali,WANG Wei.Correlation Between Early Peak Filling Rate and Diastolic Function in Patients with Hypertrophic Cardiomyopathy Based on Cardiac Magnetic Resonance Imaging[J].Advances in Cardiovascular Diseases,2021,(11):658.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.020]
[8]蓝庆肃 武锋超 马兰虎 韩冰 徐金 彭瑜 张钲.Mavacamten治疗肥厚型心肌病的研究进展[J].心血管病学进展,2021,(11):1028.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
LAN Qingsu,WU Fengchao,MA Lanhu,et al.Mavacamten in Treatment of Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(11):1028.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[9]李传伟,罗浩,曾春雨.肥厚型心肌病室间隔消减策略的研究进展[J].心血管病学进展,2022,(1):7.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.002]
LI Chuanwei,LUO Hao,ZENG Chunyu.Septal Reduction Therapy of Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(11):7.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.002]
[10]李珂 赵海娟 赵耀 黄松群 郭志福.肥厚型心肌病合并心房颤动的导管消融[J].心血管病学进展,2022,(5):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]
LI Ke,ZHAO Haijuan,ZHAO Yao,et al.Catheter Ablation of Hypertrophic Cardiomyopathy with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(11):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]